Healthcare provider profile · identity verified

Byron Kent Grayson, P.A

Physician Assistant · SURPRISE, AZ · NPI 1346299021

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Trazodone Hcl	Trazodone Hcl	553	111
Atorvastatin Calcium	Atorvastatin Calcium	513	86
Quetiapine Fumarate	Quetiapine Fumarate	466	91
Levothyroxine Sodium	Levothyroxine Sodium	405	81
Gabapentin	Gabapentin	394	72
Furosemide	Furosemide	347	67
Amlodipine Besylate	Amlodipine Besylate	321	66
Potassium Chloride	Potassium Chloride	287	57
Pantoprazole Sodium	Pantoprazole Sodium	267	50
Lisinopril	Lisinopril	263	50
Metformin Hcl	Metformin Hcl	259	44
Escitalopram Oxalate	Escitalopram Oxalate	258	45
Sertraline Hcl	Sertraline Hcl	258	47
Donepezil Hcl	Donepezil Hcl	241	44
Losartan Potassium	Losartan Potassium	223	42
Eliquis	Apixaban	219	45
Omeprazole	Omeprazole	216	42
Metoprolol Tartrate	Metoprolol Tartrate	202	33
Tamsulosin Hcl	Tamsulosin Hcl	184	37
Divalproex Sodium	Divalproex Sodium	179	38
Mirtazapine	Mirtazapine	178	37
Metoprolol Succinate	Metoprolol Succinate	174	39
Memantine Hcl	Memantine Hcl	155	33
Risperidone	Risperidone	149	36
Famotidine	Famotidine	141	31
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	134	80
Rosuvastatin Calcium	Rosuvastatin Calcium	115	27
Fluoxetine Hcl	Fluoxetine Hcl	111	19
Citalopram Hbr	Citalopram Hydrobromide	108	21
Clopidogrel	Clopidogrel Bisulfate	108	20
Buspirone Hcl	Buspirone Hcl	107	18
Duloxetine Hcl	Duloxetine Hcl	105	18
Lorazepam	Lorazepam	105	45
Carbidopa-Levodopa	Carbidopa/Levodopa	103	17
Olanzapine	Olanzapine	97	21
Tramadol Hcl	Tramadol Hcl	97	31
Carvedilol	Carvedilol	96	17
Aripiprazole	Aripiprazole	95	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	81	20
Oxycodone Hcl	Oxycodone Hcl	80	19
Oxybutynin Chloride Er	Oxybutynin Chloride	79	12
Hydralazine Hcl	Hydralazine Hcl	76	20
Alendronate Sodium	Alendronate Sodium	75	suppressed
Oxcarbazepine	Oxcarbazepine	74	23
Fluticasone Propionate	Fluticasone Propionate	72	20
Levetiracetam	Levetiracetam	71	suppressed
Simvastatin	Simvastatin	71	11
Venlafaxine Hcl Er	Venlafaxine Hcl	69	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	68	18
Montelukast Sodium	Montelukast Sodium	67	12
Megestrol Acetate	Megestrol Acetate	60	12
Spironolactone	Spironolactone	60	11
Xarelto	Rivaroxaban	60	11
Midodrine Hcl	Midodrine Hcl	58	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	56	42
Lamotrigine	Lamotrigine	56	suppressed
Cephalexin	Cephalexin	55	40
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	suppressed
Nystatin	Nystatin	54	31
Pravastatin Sodium	Pravastatin Sodium	54	suppressed
Haloperidol	Haloperidol	53	15
Hydrochlorothiazide	Hydrochlorothiazide	53	13
Glipizide	Glipizide	52	suppressed
Primidone	Primidone	52	suppressed
Alprazolam	Alprazolam	51	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	51	13
Meloxicam	Meloxicam	48	suppressed
Bumetanide	Bumetanide	46	17
Ondansetron Hcl	Ondansetron Hcl	46	31
Nifedipine Er	Nifedipine	45	suppressed
Atenolol	Atenolol	42	12
Temazepam	Temazepam	42	suppressed
Prednisone	Prednisone	41	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	12
Doxazosin Mesylate	Doxazosin Mesylate	40	suppressed
Propranolol Hcl	Propranolol Hcl	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	18
Baclofen	Baclofen	35	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	23
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Levofloxacin	Levofloxacin	35	31
Loperamide	Loperamide Hcl	34	23
Methotrexate	Methotrexate Sodium	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Azithromycin	Azithromycin	33	28
Celecoxib	Celecoxib	33	suppressed
Doxepin Hcl	Doxepin Hcl	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	13
Ezetimibe	Ezetimibe	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Latanoprost	Latanoprost	29	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Digoxin	Digoxin	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Myrbetriq	Mirabegron	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Finasteride	Finasteride	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Benztropine Mesylate	Benztropine Mesylate	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	19	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Methylprednisolone	Methylprednisolone	19	14
Triamcinolone Acetonide	Triamcinolone Acetonide	19	13
Clonidine Hcl	Clonidine Hcl	18	suppressed
Levemir Flexpen	Insulin Detemir	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Linzess	Linaclotide	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Fluconazole	Fluconazole	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Ondansetron Odt	Ondansetron	16	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Metformin Hcl Er	Metformin Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Cefdinir	Cefdinir	14	11
Colestipol Hcl	Colestipol Hcl	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Lactulose	Lactulose	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Loxapine	Loxapine Succinate	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Timolol Maleate	Timolol Maleate	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Methimazole	Methimazole	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed
Rytary	Carbidopa/Levodopa	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error